FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

FDA Drug Approval Summaries: Fulvestrant

Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur
Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur

June 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

Serena Ricciardi
Silverio Tomao
Filippo de Marinis

September 2009

Serena Ricciardi1, Silverio Tomao2, Filippo de Marinis11Thoracic-Oncology Unit 1st, Lung Diseases De...

FDA Drug Approval Summaries: Fulvestrant

Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur
Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur

June 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Richard Pazdur
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2004

located on the World Wide Web at: The online version of this article, along with updated information...

FDA drug approval summaries: pemetrexed (Alimta

Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur
Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA drug approval summaries: pemetrexed (Alimta

Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur
Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur
Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension

Richard Pazdur
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension

Richard Pazdur
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed

Steven F Powell
Arkadiusz Z Dudek

June 2009

Steven F Powell1, Arkadiusz Z Dudek21Department of Medicine, University of Minnesota, Minneapolis, M...

FDA drug approval summary: erlotinib (Tarceva

Martin H. Cohen
John R. Johnson
Yeh-fong Chen
Rajeshwari Sridhara
Guest On M
Martin H. Cohen
John R. Johnson
Yeh-fong Chen
Rajeshwari Sridhara
Richard Pazdur

January 2005

The online version of this article, along with updated information and services, is located o

Pemetrexed Disodium: A Novel Antifolate Clinically Active Against Multiple Solid Tumors

Axel-r. Hanauske
Victor Chen
Paolo Paoletti
Clet Niyikiza
Axel-r. Hanauske
Victor Chen
Paolo Paoletti
Clet Niyikiza

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summaries: Fulvestrant

Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur
Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur

June 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

Serena Ricciardi
Silverio Tomao
Filippo de Marinis

September 2009

Serena Ricciardi1, Silverio Tomao2, Filippo de Marinis11Thoracic-Oncology Unit 1st, Lung Diseases De...

FDA Drug Approval Summaries: Fulvestrant

Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur
Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur

June 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Richard Pazdur
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Martin H. Cohen
John R. Johnson
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2004

located on the World Wide Web at: The online version of this article, along with updated information...

FDA drug approval summaries: pemetrexed (Alimta

Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur
Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA drug approval summaries: pemetrexed (Alimta

Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur
Maitreyee Hazarika
Robert M. White
John R. Johnson
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Alemtuzumab as Single-Agent Treatment for B-Cell Chronic Lymphocytic Leukemia

Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur
Suzanne Demko
Jeffrey Summers
Patricia Keegan
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

January 1634

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Lapatinib in Combination with Capecitabine for Previously Treated Metastatic Breast Cancer That

Robert Justice
Richard Pazdur
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Overexpresses Her
Qin Ryan
Amna Ibrahim
Martin H. Cohen
John Johnson
Chia-wen Ko
Rajeshwari Sridhara
Robert Justice
Richard Pazdur

February 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension

Richard Pazdur
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Azacitidine (5-azacytidine, Vidaza™) for Injectable Suspension

Richard Pazdur
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Edvardas Kaminskas
Ann T. Farrell
Yong-cheng Wang
Rajeshwari Sridhara
Richard Pazdur

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Tailoring treatment of nonsmall cell lung cancer by tissue type: role of pemetrexed

Steven F Powell
Arkadiusz Z Dudek

June 2009

Steven F Powell1, Arkadiusz Z Dudek21Department of Medicine, University of Minnesota, Minneapolis, M...

FDA drug approval summary: erlotinib (Tarceva

Martin H. Cohen
John R. Johnson
Yeh-fong Chen
Rajeshwari Sridhara
Guest On M
Martin H. Cohen
John R. Johnson
Yeh-fong Chen
Rajeshwari Sridhara
Richard Pazdur

January 2005

The online version of this article, along with updated information and services, is located o

Pemetrexed Disodium: A Novel Antifolate Clinically Active Against Multiple Solid Tumors

Axel-r. Hanauske
Victor Chen
Paolo Paoletti
Clet Niyikiza
Axel-r. Hanauske
Victor Chen
Paolo Paoletti
Clet Niyikiza

January 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summaries: Fulvestrant

Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur
Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur

June 2015

located on the World Wide Web at: The online version of this article, along with updated information...

Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer

Serena Ricciardi
Silverio Tomao
Filippo de Marinis

September 2009

Serena Ricciardi1, Silverio Tomao2, Filippo de Marinis11Thoracic-Oncology Unit 1st, Lung Diseases De...

FDA Drug Approval Summaries: Fulvestrant

Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur
Peter F. Bross
Martin H. Cohen
Grant A. Williams
Richard Pazdur

June 2015

located on the World Wide Web at: The online version of this article, along with updated information...

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Abstract

Extracted data

FDA Drug Approval Summary: Pemetrexed for Injection (Alimta®) for the Treatment of Non-Small Cell Lung Cancer

Abstract

Extracted data

Related items

Related items